Regencell Bioscience Holdings Limited (id:5375 RGC)
5.87 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 4:03:19 PM)
Exchange closed, opens in 1 day 17 hours
3.70 USD (3.70%)
-7.56 USD (-7.56%)
3.53 USD (3.53%)
17.17 USD (17.17%)
-51.08 USD (-51.08%)
-51.08 USD (-51.08%)
About Regencell Bioscience Holdings Limited
Market Capitalization 76.39M
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
| Headquarters (address) |
Chinachem Leighton Plaza Causeway Bay Hong Kong |
| Phone | 852 2155 0823 |
| Website | https://www.regencellbioscience.com |
| Employees | 12 |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty & Generic |
| Ticker | RGC |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 3.03 - 32.44 |
| Market Capitalization | 76.39M |
| Price/Book | 9.29 |
| Beta | -0.602 |
| EPS | -0.330 |
| EPS Hong Kong (ID:164, base:20) | 0.100 |